If you are having trouble viewing this email, please click here.

   Axtria

Axtria Collective - Nov-Dec_740x250_opt2

Welcome to The Axtria Collective!

In this year-end issue, we bring you the best thought leadership, including Integrated Advanced Data Analytics in Support of RWE, Pharma’s Future Field Force & Leadership’s Role in Enabling the Transformation, and much more! Enjoy!

AWARDS AND ACHIEVEMENTS Group 47570

MicrosoftTeams-image (33)

Jaswinder Chadha Receives IIT Delhi’s Distinguished Alumni Award

Axtria CEO & Co-Founder Jaswinder Chadha Receives IIT Delhi’s Distinguished Alumni Award from Renowned Economist and Nobel Laureate Professor Abhijit Banerjee.

READ MORE

TRENDING WHITE PAPER Group 47570

MicrosoftTeams-image (34)

Seeing the Whole Elephant: Integrated Advanced Data Analytics in Support of RWE

In this white paper, Won Chan Lee, Ph.D., Principal, and Head of HEOR/RWE Practice at Axtria, draws on the fable of the six blind men and the elephant to describe how life sciences companies can harness varied real-world data sources to generate comprehensive, actionable insights.

DOWNLOAD NOW

KNOWLEDGE STREAM Group 47570

MicrosoftTeams-image (28)-1

Pharma’s Future Field Force & Leadership’s Role in Enabling the Transformation

Traditional reach - and frequency-based approaches are no longer adequate for pharma selling. Listen to this podcast episode, where Vandana Singh, Principal at Axtria, explores how the transformation of sales operations can revolutionize field force outcomes in the virtual world.

LISTEN NOW

JASSI'S KEYNOTE AT REUTERS EVENTSTM PHARMA 2022 Upcoming event

Reuters Events

Patient Engagement – What History Teaches us About Pharma’s Future Evolution

Watch Jassi Chadha’s keynote at the Reuters Events™ Pharma 2022 to learn how pharma companies can build an effective patient engagement strategy to ensure the success of omnichannel efforts.

WATCH NOW

LEADERS' PERSPECTIVES   Leaders Perspective

MicrosoftTeams-image (32)

Betting the House on Orphan Drugs

Despite the commercial challenges of orphan drugs, many biopharmaceutical companies are staking a claim in the rare disease treatment space. In this article, Axtria’s expert Animesh Arun and other biopharma leaders share their points of view, which could yield clinical and financial rewards.

READ MORE

MicrosoftTeams-image (31)

Optimizing Your Biggest Promotional Channel

Companies must carefully design omnichannel programs that respect field teams' unique knowledge and capabilities. In this whitepaper, Charles Rink, Global Omnichannel Lead at Axtria, proposes some practical answers to two critical questions and discusses practical ways to make it happen.

DOWNLOAD WHITE PAPER

 TIMELESS INSIGHTS   Group 47571

Blog-3

BLOG

Impact of IDN Consolidation on the MedTech Sales Function

Given the current rate of acquisitions and the frequency with which hospitals shift ownership, the impact on MedTech sales teams can be nuanced and complex. This article tells about the challenges presented by M&As in the healthcare industry and how to deal with them.

READ MORE

Blog-3

BLOG

The Future of MedTech Sales - Embracing Hybrid Customer Engagement

At a time when sales reps embrace tech and customers expect high-impact engagement, MedTech has an unprecedented opportunity to digitize sales channels, build hybrid sales teams, and create a truly omnichannel customer experience.

READ MORE

Blog-3

BLOG

Three Data Analytics Opportunities in Animal Health to Watch Out For

Sophisticated data analytics solutions can help improve the overall customer experience and maximize commercial returns. In this article, Axtria discusses three emerging trends for analytics in the animal health industry.

READ MORE

NEWS CAPSULE News

Axtria Presents Two HEOR/RWE Studies at ISPOR Europe 2022
Axtria presented two posters at the ISPOR Europe 2022 conference that combine different modeling methods with the latest advanced analytics technologies. Both highlighted the clinical and economic benefits of anti-arrhythmic drugs (AADs) for treating atrial fibrillation (AFib) and insulin glargine for treating type 2 diabetes. Read More >>

Celebrating 100K+ Followers
Axtria has reached two milestones! We now have 100K followers on LinkedIn and 20K+ followers to our newsletter on LinkedIn. We thank our partners, clients, associates, and all followers for their support and for accompanying us on this exciting journey. Watch More >>

Axtria’s CSR Initiative
Axtria's Corporate Social Responsibility (CSR) team volunteers shared the festive spirit with kids from a public school in Gurugram, where they organized various fun activities. The "How to Introduce Yourself" session was a huge success. ⁠Read More >>

Are you looking for your next career opportunity?
Come and be part of the Axtria family! Click here to explore growth opportunities.

Did you enjoy reading this newsletter?

Thumbs 1 Thumbs 2

Sign up for insights delivered to your inbox every month. 

   
If you are having trouble viewing this email, please click here.

 Unsubscribe from all future emails